Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susanne Beck

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
British Journal of Cancer|January 13, 2026
Diagnostic whole transcriptome sequencing in a series of 1233 FFPE solid tumor samplesMarkus Ball, Susanne Beck, Darius Wlochowitz, et al.
British Journal of Cancer|March 2, 2026
Correction: Diagnostic whole transcriptome sequencing in a series of 1233 FFPE solid tumor samplesMarkus Ball, Susanne Beck, Darius Wlochowitz, et al.
Journal of Hematology & Oncology|December 19, 2024
Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myelomaDirk Hose, Seemun Ray, Sina Rößler, et al.
Journal of Hematology & Oncology|January 25, 2025
Correction: Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myelomaDirk Hose, Seemun Ray, Sina Rößler, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
British Journal of Cancer|January 13, 2026
Diagnostic whole transcriptome sequencing in a series of 1233 FFPE solid tumor samplesMarkus Ball, Susanne Beck, Darius Wlochowitz, et al.
British Journal of Cancer|March 2, 2026
Correction: Diagnostic whole transcriptome sequencing in a series of 1233 FFPE solid tumor samplesMarkus Ball, Susanne Beck, Darius Wlochowitz, et al.
Journal of Hematology & Oncology|December 19, 2024
Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myelomaDirk Hose, Seemun Ray, Sina Rößler, et al.
Journal of Hematology & Oncology|January 25, 2025
Correction: Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myelomaDirk Hose, Seemun Ray, Sina Rößler, et al.
Pageof 5